Molecular Templates, Inc.

OTCPK:MTEM Stock Report

Market Cap: US$85.6k

Molecular Templates Management

Management criteria checks 2/4

Molecular Templates' CEO is Eric Poma, appointed in Jan 2009, has a tenure of 7.42 years. total yearly compensation is $857.77K, comprised of 72.4% salary and 27.6% bonuses, including company stock and options. directly owns 0.28% of the company’s shares, worth $240.59. The average tenure of the management team and the board of directors is 1.4 years and 7.4 years respectively.

Key information

Eric Poma

Chief executive officer

US$857.8k

Total compensation

CEO salary percentage72.4%
CEO tenure16yrs
CEO ownership0.3%
Management average tenure1.4yrs
Board average tenure7.4yrs

Recent management updates

Recent updates

There's No Escaping Molecular Templates, Inc.'s (NASDAQ:MTEM) Muted Revenues Despite A 30% Share Price Rise

Oct 10
There's No Escaping Molecular Templates, Inc.'s (NASDAQ:MTEM) Muted Revenues Despite A 30% Share Price Rise

Earnings Release: Here's Why Analysts Cut Their Molecular Templates, Inc. (NASDAQ:MTEM) Price Target To US$18.00

Aug 17
Earnings Release: Here's Why Analysts Cut Their Molecular Templates, Inc. (NASDAQ:MTEM) Price Target To US$18.00

Molecular Templates, Inc.'s (NASDAQ:MTEM) Shares Bounce 27% But Its Business Still Trails The Industry

Jul 30
Molecular Templates, Inc.'s (NASDAQ:MTEM) Shares Bounce 27% But Its Business Still Trails The Industry

Little Excitement Around Molecular Templates, Inc.'s (NASDAQ:MTEM) Revenues As Shares Take 48% Pounding

Apr 03
Little Excitement Around Molecular Templates, Inc.'s (NASDAQ:MTEM) Revenues As Shares Take 48% Pounding

Lacklustre Performance Is Driving Molecular Templates, Inc.'s (NASDAQ:MTEM) 26% Price Drop

Dec 20
Lacklustre Performance Is Driving Molecular Templates, Inc.'s (NASDAQ:MTEM) 26% Price Drop

There's No Escaping Molecular Templates, Inc.'s (NASDAQ:MTEM) Muted Revenues Despite A 45% Share Price Rise

Apr 17
There's No Escaping Molecular Templates, Inc.'s (NASDAQ:MTEM) Muted Revenues Despite A 45% Share Price Rise

What Does The Future Hold For Molecular Templates, Inc. (NASDAQ:MTEM)? These Analysts Have Been Cutting Their Estimates

Nov 16
What Does The Future Hold For Molecular Templates, Inc. (NASDAQ:MTEM)? These Analysts Have Been Cutting Their Estimates

Time To Worry? Analysts Are Downgrading Their Molecular Templates, Inc. (NASDAQ:MTEM) Outlook

Aug 14
Time To Worry? Analysts Are Downgrading Their Molecular Templates, Inc. (NASDAQ:MTEM) Outlook

Molecular Templates GAAP EPS of -$0.44 misses by $0.01, revenue of $4.42M misses by $2.6M

Aug 11

Rock star Growth Puts Molecular Templates (NASDAQ:MTEM) In A Position To Use Debt

Apr 29
Rock star Growth Puts Molecular Templates (NASDAQ:MTEM) In A Position To Use Debt

Health Check: How Prudently Does Molecular Templates (NASDAQ:MTEM) Use Debt?

Dec 30
Health Check: How Prudently Does Molecular Templates (NASDAQ:MTEM) Use Debt?

Some Analysts Just Cut Their Molecular Templates, Inc. (NASDAQ:MTEM) Estimates

Nov 25
Some Analysts Just Cut Their Molecular Templates, Inc. (NASDAQ:MTEM) Estimates

Is Molecular Templates (NASDAQ:MTEM) Using Debt In A Risky Way?

Sep 22
Is Molecular Templates (NASDAQ:MTEM) Using Debt In A Risky Way?

News Flash: Analysts Just Made A Notable Upgrade To Their Molecular Templates, Inc. (NASDAQ:MTEM) Forecasts

Aug 15
News Flash: Analysts Just Made A Notable Upgrade To Their Molecular Templates, Inc. (NASDAQ:MTEM) Forecasts

Need To Know: Analysts Just Made A Substantial Cut To Their Molecular Templates, Inc. (NASDAQ:MTEM) Estimates

May 18
Need To Know: Analysts Just Made A Substantial Cut To Their Molecular Templates, Inc. (NASDAQ:MTEM) Estimates

Brokers Are Upgrading Their Views On Molecular Templates, Inc. (NASDAQ:MTEM) With These New Forecasts

Mar 21
Brokers Are Upgrading Their Views On Molecular Templates, Inc. (NASDAQ:MTEM) With These New Forecasts

Need To Know: The Consensus Just Cut Its Molecular Templates, Inc. (NASDAQ:MTEM) Estimates For 2021

Feb 21
Need To Know: The Consensus Just Cut Its Molecular Templates, Inc. (NASDAQ:MTEM) Estimates For 2021

CEO Compensation Analysis

How has Eric Poma's remuneration changed compared to Molecular Templates's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$16m

Mar 31 2024n/an/a

-US$18m

Dec 31 2023US$858kUS$621k

-US$8m

Sep 30 2023n/an/a

-US$26m

Jun 30 2023n/an/a

-US$47m

Mar 31 2023n/an/a

-US$60m

Dec 31 2022US$2mUS$600k

-US$93m

Sep 30 2022n/an/a

-US$81m

Jun 30 2022n/an/a

-US$87m

Mar 31 2022n/an/a

-US$78m

Dec 31 2021US$4mUS$577k

-US$83m

Sep 30 2021n/an/a

-US$101m

Jun 30 2021n/an/a

-US$94m

Mar 31 2021n/an/a

-US$110m

Dec 31 2020US$5mUS$560k

-US$105m

Sep 30 2020n/an/a

-US$92m

Jun 30 2020n/an/a

-US$107m

Mar 31 2020n/an/a

-US$85m

Dec 31 2019US$2mUS$515k

-US$69m

Sep 30 2019n/an/a

-US$60m

Jun 30 2019n/an/a

-US$27m

Mar 31 2019n/an/a

-US$28m

Dec 31 2018US$4mUS$500k

-US$30m

Compensation vs Market: Eric's total compensation ($USD857.77K) is above average for companies of similar size in the US market ($USD649.07K).

Compensation vs Earnings: Eric's compensation has been consistent with company performance over the past year.

CEO

Eric Poma (52 yo)

16yrs

Tenure

US$857,769

Compensation

Dr. Eric E. Poma, Ph D., is the Chief Executive Officer and Chief Scientific Officer of Molecular Templates, Inc. since 2009 and served as its President and also serves as its Interim Chief Financial Offic...

Leadership Team

NamePositionTenureCompensationOwnership
Eric Poma
Interim CFO16yrsUS$857.77k0.28%
$ 240.6
Kristen Quigley
Chief Operating Officer1.4yrsno datano data
Grace Kim
Chief Strategy Officer & Head of IR1.4yrsno datano data
Michelle Iwamoto-Fan
Senior Vice President & General Counselless than a yearno datano data
Joseph Phillips
Senior VP & Head of CMC Developmentno datano datano data
Chris Moore
Senior VP and Head of Preclinical Development & Translational Medicineless than a yearno datano data

1.4yrs

Average Tenure

Experienced Management: MTEM's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Eric Poma
Interim CFO7.4yrsUS$857.77k0.28%
$ 240.6
Michel Klein
Member of Scientific Advisory Boardno datano datano data
David Hoffmann
Independent Director7.4yrsUS$59.29k0%
$ 0
Harold Selick
Independent Chairman7.4yrsUS$87.29k0.041%
$ 35.4
Kevin Lalande
Independent Director7.4yrsUS$54.29k0%
$ 0
Corazon Sanders
Independent Director5.1yrsUS$49.29k0%
$ 0
Burkhard Jansen
Member of Scientific Advisory Boardno datano datano data
Neil Berinstein
Member of Scientific Advisory Boardno datano datano data
Gabriela Gruia
Director2.8yrsUS$561.35k0%
$ 0

7.4yrs

Average Tenure

67yo

Average Age

Experienced Board: MTEM's board of directors are considered experienced (7.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 23:26
End of Day Share Price 2025/01/03 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Molecular Templates, Inc. is covered by 8 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Carter GouldBarclays
Tazeen AhmadBofA Global Research
Roger SongJefferies LLC